Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Loading...
Community
/
United States
/
Healthcare
/
Progyny
Create a narrative
Progyny Community
NasdaqGS:PGNY Community
3
Narratives
written by author
0
Comments
on narratives written by author
40
Fair Values set
on narratives written by author
Community Investing Ideas
Progyny
Popular
Undervalued
Overvalued
Progyny
AN
AnalystConsensusTarget
Based on Analyst Price Targets
Rising Demand For Women's Health Will Transform Market Opportunity
Key Takeaways Expanding employer focus on women's health and demographic shifts drive robust, recurring demand and client growth for Progyny's fertility benefits and services. Integrated health platform investments and successful upselling boost revenue diversity, client retention, and margin growth while reducing risk from industry concentration.
View narrative
US$28.25
FV
24.0% undervalued
intrinsic discount
8.87%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
23
users have followed this narrative
18 days ago
author updated this narrative
Progyny
AN
AnalystHighTarget
Community Contributor
Delayed Parenthood And Healthcare Consumerism Will Boost Fertility Ecosystem
Key Takeaways Expanding partnerships and platform innovations are driving stronger insurer adoption, enhancing utilization and pricing power, and positioning the company as essential for employer-offered fertility benefits. Strategic alliances, robust cash flow, and rising demand from younger employees enable brand leadership, accelerating organic growth and offering high optionality for future expansion.
View narrative
US$32
FV
32.9% undervalued
intrinsic discount
12.84%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
18 days ago
author updated this narrative
Progyny
AN
AnalystLowTarget
Community Contributor
Tightening US Healthcare Policies And Gig Shifts Will Dampen Prospects
Key Takeaways Policy shifts and workforce trends threaten to shrink Progyny's eligible customer base and dampen long-term growth prospects. Intensifying competition, regulatory scrutiny, and disruptive technologies pose risks to profitability, client retention, and future demand for services.
View narrative
US$21
FV
2.2% overvalued
intrinsic discount
6.25%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 1 month ago
author updated this narrative